E W Salzman1. Show Affiliations » 1. Department of Surgery, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts 02215.
Abstract
Entities: Chemical Disease
Mesh: See more » Cost-Benefit AnalysisHeparin/administration & dosageHeparin/therapeutic useHumansPostoperative Complications/prevention & controlRisk FactorsThrombophlebitis/economicsThrombophlebitis/prevention & control
Substances: See more » Heparin
Year: 1989 PMID: 2500050 DOI: 10.1111/j.1749-6632.1989.tb22518.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691